Stamaril Use In Pregnancy & Lactation

Pregnancy: No animal developmental and reproductive studies have been conducted with STAMARIL and the potential risk for humans is unknown. Data on a limited number of exposed pregnancies indicate no adverse effects of STAMARIL on pregnancy or the health of the foetus/newborn child. Nevertheless, STAMARIL is a live attenuated vaccine, it should not be used during pregnancy unless clearly needed and only after careful consideration of the potential risks and benefits. Pregnancy should be avoided in the month after the vaccination.
Breast-feeding: As there is a probable risk of transmission of the vaccine virus strain to the infants from breastfeeding mothers, STAMARIL should not be given to nursing mothers unless when clearly needed such as during an outbreak and only if the potential benefits to the mother are higher than the potential risks, including those for the breastfed child (see Precautions). In the case where vaccination is needed, it is recommended to discontinue breast-feeding for at least 2 weeks after vaccination.
Fertility: No animal fertility studies have been conducted with STAMARIL and no fertility data are available in humans.